dr. laura guay vice president for research elizabeth glaser pediatric aids foundation

27
Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation Research Professor, George Washington University School of Public Health and Health Services Early Infant Diagnosis of HIV: Successes, Challenges, and potential solutions

Upload: alamea

Post on 10-Feb-2016

34 views

Category:

Documents


0 download

DESCRIPTION

Early Infant Diagnosis of HIV: Successes, Challenges, and potential solutions. Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation Research Professor, George Washington University School of Public Health and Health Services. Provision of Antiretroviral Drugs. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Dr. Laura Guay

Vice President for ResearchElizabeth Glaser Pediatric AIDS Foundation

Research Professor, George Washington University School of Public Health and Health Services

Early Infant Diagnosis of HIV: Successes, Challenges, and potential

solutions

Page 2: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

2004 2005 2006 2007 20080%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

10%

15%

24%

34%

45%

6%

12%

18%20%

32%

Pregnant women living with HIV receiving ARVsInfants born to pregnant women living with HIV receiving ARVs

Provision of Antiretroviral Drugs

WHO, UNAIDS, UNICEF - Towards Universal Access: Progress Report 2009

55% of pregnant womennot receiving PMTCT

drugs

68% of HIV-exposed infants

not receiving PMTCT drugs

Page 3: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Pearl Study: Coverage Cascade in HIV+ WomenCoetzee D et al. IAS, Capetown, South Africa, July 2009, Abs. WeLBD101

0 1000 2000 3000 4000

HIV-positive deliveries (100%)

Services documented (92%)

HIV test offered (84%)

HIV tested (81%)

Received positive result (74%)

Mother received NVP (71%)

NVP in cord blood (57%)

Completed prophylaxis (50%)

Page 4: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 5: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Identification of HIV exposed infants

Low rate of return for 4-6 week postnatal visit

• Tingathe community health workers- Malawi• Pregnant women introduction to and appointment for

postnatal referral clinic- Uganda• Community testing days- Lesotho

Failure to identify an infant as HIV exposed

• Maternal PMTCT status codes on immunization card• Revised maternal/infant health card- PMTCT/EID status• Routine maternal PMTCT history • Screening for HIV exposure at all contacts with HC,

particularly EPI clinics (rapid DBS)

Page 6: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 7: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Specimen obtained for HIV testing

Limited number of laboratories with PCR capacity

• In-country capacity developed- Lesotho, Swazi• Decentralization of lab capacity• Hub and spoke regional service system- Kenya, Uganda

Low facility coverage of EID services (limited manpower, time, commodities, transport)

• Rapid roll-out of EID access (training, supplies)• Strong linkages between sites with and without testing

capacity – Uganda• Moving specimen collection to MCH rather than lab

Page 8: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Specimen obtained for HIV testing

Lack of trained HCW (staff attrition, rotation)

• Health system wide training• Mentorship program (clinical and system) -

CHAI/MOH Zambia• Ongoing training, supervision

Low testing acceptance rate (lack of knowledge, fear of knowing results, no ART access)

• Training and buy-in from HCW- Zimbabwe• Focused counseling prior to and after delivery• Community sensitization

Page 9: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Specimen obtained for HIV testing

Stock out of testing supplies

• Bundling of supplies- Zimbabwe• Training in inventory management, forecasting• Supply chain management

Inadequate specimen transport system

• Dried blood spot use- significant advantage• Focused local effort to determine best system• Creative use of existing (non-health) transport systems

with broad reach – Post, EMS, bus, newspaper delivery• Distal access via bikes, motorcycles, personnel

Page 10: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 11: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Test results returned to clinic from lab

Extremely long turn around time (months)

• Support for data clerks in lab to process results• Increased frequency of result collection- Tanzania• Use of technology to replace paper based system email- Lesotho; cell phone- Mozambique

Insufficient/inadequate sample

• Regular communication between lab and clinic• QI initiatives involving lab and clinics• Ongoing HCW training/supervision

Page 12: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Test results returned to clinic from lab

Poor specimen/result tracking

• Electronic EID/laboratory database- Swaziland• Use of multiple page laboratory request forms

Inadequate systems for accurate documentation in clinic

• Revised clinic registers with places for documenting “EID cascade”• Clear systems for managing results when received• Clear lines of responsibility for handling results received,

recording in medical records

Page 13: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 14: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Determining HIV Test Result

Limited availability of well trained laboratory technicians (technical skills, attrition)

• Laboratory training/mentorship programs• Incentives to remain in public sector• Development of technology requiring less technical

skills

Insufficient lab capacity for volume

• Lab capacity expansion = EID scale-up• Improved inventory management, forecasting for

commodities, supply chain management

Page 15: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Determining HIV Test Result

Weak QA/QC systems

• Quality focus not just quantity

Lack of confirmatory testing

• Minimize specimen contamination risk• Minimize specimen/labeling mix-up• Development of an efficient, cost-effective system for

confirmation of infection status

Indeterminate test results

• SOPs for managing indeterminate/inconsistent results

Page 16: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 17: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Test results received by caretaker Low rate of return for results

• Improved turn around time will decrease frustration from multiple return visits without results

• Enhanced counseling on importance of infant diagnosis• Patient friendly clinic services

Lack of urgency in responding to positive results

• Sensitization of HCW on impact of delayed diagnosis• Rapid result review and response system in place

Disorganized system for documenting results when returned to the clinic

• SOP for ensuring results accessible when caretaker returns

Page 18: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Test results received by caretaker Lack of active patient tracking system

• Use of peers, support groups, community workers

Concern about counseling women on infant status- both for negative and infected infants

• Training, counseling aids to decrease discomfort with providing infant status while ongoing exposure

• Re-training on implications of new WHO guidelines for postnatal prophylaxis

• Quality infant feeding counseling to minimize premature discontinuation of breastfeeding

• System in place for referral of HIV infected infants to care and treatment

Page 19: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 20: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Enrollment in HIV Care (infected infants)

Poor linkages between PMTCT and HIV Care and Treatment Programs (bi-directional)

• ART in MCH for women/infants- Lesotho, Swazi• Consultation/collaboration between PMTCT and

ART clinics to determine best method for referral Personal Escort between services (staff, peers) Referral system with feedback to identify those lost System of shared data capture for prospective f/up Prioritized services for infants

Page 21: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Enrollment in HIV Care (infected infants)

Loss to follow-up between service delivery points

• Active follow-up system in place

Limited knowledge in community and families about importance of treating infants

• Community education/sensitization campaigns• Community health workers/PMTCT champions

Page 22: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Exposed in-fants

EID drawn Results re-turned

from lab

Tested pos-itive

Received results

Enrolled in Care

Initiated on ARV

42264099 (97%)

2895 (70%)

449 (15%)230 (51%) 200 (87%) 178 (89%)

Overall , 633 infected children = 71% identified, 28% treated

Testing Status of Infants- 2009-2010

Page 23: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Initiation of ART (infected infants < 2) Limited facilities providing ART to infants

• Decentralization of pediatric care and treatment services• Policy changes allowing non- physician ART prescribing

and provision of HIV care and treatment (including infants)• ART integration in MCH using MCH nursing

Inadequate stocks of ARV formulations appropriate for infants

• Collaboration with Pharma on identifying priority needs (IATT, IAS)• Accurate forecasting, supply chain management to

periphery

Page 24: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Initiation of ART (infected infants < 2)

Lack of experience/comfort treating infants

• Expanded Pediatric ART training/re-training with new WHO guidelines• Clinical mentorship programs with extensive and

prolonged mentor contact• Exchange visits between experienced and new service

delivery sites• Comprehensive job aids and decision trees/algorithms

WHO recommends presumptive treatment in absence of virologic testing but providers reluctant to initiate ART in infants without definitive diagnosis

Page 25: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Way Forward• Maximize efforts at each step of the cascade(s)

• Identify and address gaps in the health system (manpower, lab capacity, data collection, training, logistics)

• Creative use of new technologies

• Point of Care or at least Closer to Care early infant diagnostics

• Community sensitization/engagement

Page 26: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

ConclusionPMTCT program goal 1 - prevent infant HIV infections, yet ability to monitor HIV transmission rates to determine progress remains elusive

PMTCT program goal 2 – identify HIV infected infants as early as possible to decrease morbidity and mortality yet universal determination of HIV status remains elusive

Universal access to rapid, high quality, early infant diagnosis requires universal commitment, collaboration, and innovation

Page 27: Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation

Tunaweza: Together, we can…

Eliminate Pediatric HIV